https://european-biotechnology.net/wp-content/uploads/2026/02/Team_Immunic.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-13 16:06:422026-02-13 16:06:42Immunic secured US$400 million to conclude phase 3 MS program and prepare for launch
https://european-biotechnology.net/wp-content/uploads/2026/02/glen-rushton-Uwl7TRuTZqE-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-13 13:01:002026-02-13 13:01:00Amgen wins European approval to challenge argenx and UCB for autoimmune market
https://european-biotechnology.net/wp-content/uploads/2026/02/wesley-tingey-ak5yDsh1kDQ-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-13 12:48:472026-02-13 12:48:47GENFIT to receive $20M milestone from Ipsen as Iqirvo tops $200M in first full year
https://european-biotechnology.net/wp-content/uploads/2026/02/maryna-yazbeck-pyzjoMvyCmw-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-12 16:08:532026-02-12 16:08:53Europe’s life sciences investors step up as biotech financing gap widens
https://european-biotechnology.net/wp-content/uploads/2026/02/vedrana-filipovic-jxqTaXF5WmY-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-12 15:39:402026-02-12 15:39:40Zeon invests in Chemify to cut compound synthesis time using AI and robotics
https://european-biotechnology.net/wp-content/uploads/2026/02/sanofi-headquarters-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-12 09:39:492026-02-12 14:32:02From Darmstadt to Paris: Belén Garijo leaves Merck to lead Sanofi after CEO exit
https://european-biotechnology.net/wp-content/uploads/2026/02/benjamin-chambon-p0oQqAzueDI-unsplash-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-11 15:36:502026-02-11 15:36:50French biopharma duo THX Pharma and Biocodex strike rare diseases licensing deal worth up to €173M
